Scarica l'app Stockscreener
388.56
0.38%
0.48
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SYK Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$388.08
Aprire:
$388.67
Volume 24 ore:
404.13K
Relative Volume:
0.26
Capitalizzazione di mercato:
$145.74B
Reddito:
$23.22B
Utile/perdita netta:
$2.86B
Rapporto P/E:
52.51
EPS:
7.4
Flusso di cassa netto:
$3.58B
1 W Prestazione:
+3.19%
1M Prestazione:
+11.21%
6M Prestazione:
+0.31%
1 anno Prestazione:
+20.03%
Intervallo 1D:
$385.78
$390.46
Intervallo di 1 settimana:
$376.30
$392.42
Portata 52W:
$314.93
$406.19
Stryker Corp Stock (SYK) Company Profile
Nome
Stryker Corp
Settore
Industria
Telefono
(269) 385-2600
Indirizzo
1941 STRYKER WAY, PORTAGE, MI
Confronta SYK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
388.50 | 145.74B | 23.22B | 2.86B | 3.58B | 7.40 |
|
ABT
Abbott Laboratories
|
129.37 | 230.70B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.39 | 154.22B | 17.55B | 2.03B | 2.72B | 1.37 |
|
MDT
Medtronic Plc
|
85.33 | 107.03B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.10 | 44.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-26 | Ripresa | Citigroup | Buy |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Outperform |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-22 | Aggiornamento | Needham | Hold → Buy |
| 2024-01-31 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | Iniziato | ROTH MKM | Buy |
| 2023-09-05 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-25 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-28 | Aggiornamento | Edward Jones | Hold → Buy |
| 2022-07-21 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-07-11 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-04-13 | Iniziato | Truist | Hold |
| 2022-03-16 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | Ripresa | Evercore ISI | Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-07-28 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-05-25 | Iniziato | Barclays | Underweight |
| 2020-10-06 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2020-04-01 | Downgrade | Goldman | Buy → Sell |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Hold |
| 2020-01-07 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | Reiterato | BTIG Research | Buy |
| 2019-11-05 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-10-30 | Reiterato | BofA/Merrill | Buy |
| 2019-07-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-01-30 | Reiterato | Canaccord Genuity | Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2019-01-02 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-08-16 | Iniziato | BTIG Research | Buy |
| 2018-06-27 | Iniziato | Bernstein | Mkt Perform |
| 2018-04-27 | Reiterato | Stifel | Buy |
Mostra tutto
Stryker Corp Borsa (SYK) Ultime notizie
Stryker: Mako Spine And Shoulder Launching Is On Track (Downgrade To Hold) (NYSE:SYK) - Seeking Alpha
Why Stryker Corporation (SYK) Is Among the Best Medical Device Stocks to Buy Now - Insider Monkey
Stryker Director Makes a Multi-Million Dollar Stock Move! - TipRanks
Stryker declares an $0.84 per share quarterly dividend - Ortho Spine News
Stryker (SYK) Announces Steady Dividend with Promising Growth Forecast - GuruFocus
Stryker raises dividend to $0.84 per share for Q2 - Investing.com
Stryker Declares An $0.84 Per Share Quarterly Dividend - Barchart.com
Here's How Much $100 Invested In Stryker 10 Years Ago Would Be Worth Today - Benzinga
Analysts Offer Insights on Healthcare Companies: Cerus (CERS), Stryker (SYK) and Praxis Precision Medicines (PRAX) - The Globe and Mail
Stryker (SYK) Receives Price Target Boost Following Strong Quart - GuruFocus
Stryker, Lockheed Martin, Rockwell Automation And More On CNBC's 'Final Trades' - Benzinga
Reflecting On Medical Devices & SuppliesDiversified Stocks’ Q1 Earnings: Stryker (NYSE:SYK) - Yahoo Finance
Stryker (SYK) Price Target Raised by Truist Securities | SYK Sto - GuruFocus
Stryker (SYK) Price Target Raised by Truist Securities | SYK Stock News - GuruFocus
UBS lifts Stryker stock price target to $421 from $405 - Investing.com
Stryker's (SYK) Price Target Raised by Truist Amid Strong Growth - GuruFocus
Demystifying Stryker: Insights From 5 Analyst Reviews - Benzinga
Stryker's (SYK) Price Target Raised by Truist Amid Strong Growth | SYK Stock News - GuruFocus
Stryker (SYK) Receives Price Target Boost Following Strong Quarterly Results | SYK Stock News - GuruFocus
Decoding Stryker Corp (SYK): A Strategic SWOT Insight - GuruFocus
Stryker Corp’s Earnings Call Highlights Robust Growth - TipRanks
Stryker (SYK) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Stryker price target raised to $456 from $405 at Roth Capital - TipRanks
Stryker says bribery probe dropped by US Justice Department - MLex
Stryker (SYK) Lands a Higher Price Target from Roth MKM | SYK Stock News - GuruFocus
Stryker (SYK) Rating Maintained, Price Target Lowered by Evercore ISI Group | SYK Stock News - GuruFocus
Stryker (SYK): Roth Capital Boosts Price Target Amid Strong Q1 P - GuruFocus
Medical Equipment Makers Stryker, Becton Eye Price Hikes to Offset Tariffs - Bloomberg
Stryker (SYK): Roth Capital Boosts Price Target Amid Strong Q1 Performance | SYK Stock News - GuruFocus
Stryker raises forecast on strong sales despite $200M tariff hit - Crain's Grand Rapids Business
Stryker Corporation (SYK) Sees Strong Q1 2025 Growth Amid Strate - GuruFocus
Stryker Corporation (NYSE:SYK) Q1 2025 Earnings Call Transcript - Insider Monkey
Stryker stock target cut to $390 by Evercore ISI - Investing.com
Stryker beats quarterly estimates of string medical device demand - Reuters
Stryker Corp Reports Strong Q1 2024 Earnings Growth - TipRanks
Stryker Corp (SYK) Q1 2025 Earnings Call Highlights: Strong Organic Growth and Strategic ... - Yahoo Finance
Stryker Corp (SYK) Q1 2025 Earnings: Revenue Surpasses Estimates at $5.9 Billion, EPS Falls Short at $1.69 - GuruFocus
Stryker Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Stryker: Q1 Earnings Snapshot - MySA
Stryker Corporation (SYK) Sees Strong Q1 2025 Growth Amid Strategic Shifts - GuruFocus
Stryker's Profits Outshine Forecasts Thanks To Device Demand - Finimize
Earnings call transcript: Stryker Q1 2025 beats EPS forecasts, stock dips By Investing.com - Investing.com South Africa
Earnings call transcript: Stryker Q1 2025 beats EPS forecasts, stock dips - Investing.com
Stryker reports first quarter 2025 operating results - ADVFN
Stryker (SYK) Surpasses Q1 Earnings and Revenue Estimates - Yahoo
Stryker earnings beat by $0.13, revenue topped estimates - Investing.com
SYK Reports Strong Q1 Revenue, Beating Expectations | SYK Stock News - GuruFocus
Stryker beats Q1 estimates, raises 2025 organic sales outlook By Investing.com - Investing.com India
Stryker beats Q1 estimates, raises 2025 organic sales outlook - Investing.com
Stryker Corp. Q1 Profit Decreases, But Beats Estimates - Nasdaq
Here's How Much $1000 Invested In Stryker 10 Years Ago Would Be Worth Today - Benzinga
Stryker Corp Azioni (SYK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.01%
0.20%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):